Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Oct 20:11:557233.
doi: 10.3389/fneur.2020.557233. eCollection 2020.

Middle Meningeal Artery Embolization for Chronic Subdural Hematoma

Affiliations
Review

Middle Meningeal Artery Embolization for Chronic Subdural Hematoma

Joshua S Catapano et al. Front Neurol. .

Erratum in

Abstract

Chronic subdural hematoma (cSDH) is a common disease process associated with significant morbidity that occurs most often in elderly patients. Asymptomatic patients are typically treated conservatively, with surgical intervention reserved for patients with symptomatic and/or large hematomas that cause brain compression. However, conservatively managed cSDH cases frequently progress, and surgical evacuation of cSDH is associated with high rates of complication and recurrence. Recently, successful treatment of cSDH via middle meningeal artery (MMA) embolization has been reported in small case series and case reports. This article reviews the existing literature on MMA embolization for cSDH and discusses the need for randomized control trials and/or large prospective studies to establish the efficacy of MMA embolization for this disease.

Keywords: MMA embolization; cSDH; chronic subdural hematoma; endovascular cSDH treatment; middle meningeal artery embolization.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Proposed treatment algorithm for chronic subdural hematoma (cSDH) with the use of middle meningeal artery (MMA) embolization. Used with permission from Barrow Neurological Institute, Phoenix, Arizona.

References

    1. Balser D, Farooq S, Mehmood T, Reyes M, Samadani U. Actual and projected incidence rates for chronic subdural hematomas in United States veterans administration and civilian populations. J Neurosurg. (2015) 123:1209–15. 10.3171/2014.9.JNS141550 - DOI - PMC - PubMed
    1. Foreman P, Goren O, Griessenauer CJ, Dalal SS, Weiner G, Schirmer CM. Middle meningeal artery embolization for chronic subdural hematomas: cautious optimism for a challenging pathology. World Neurosurg. (2019) 126:528–9. 10.1016/j.wneu.2019.03.160 - DOI - PubMed
    1. Miranda LB, Braxton E, Hobbs J, Quigley MR. Chronic subdural hematoma in the elderly: not a benign disease. J Neurosurg. (2011) 114:72–6. 10.3171/2010.8.JNS10298 - DOI - PubMed
    1. Kolias AG, Chari A, Santarius T, Hutchinson PJ. Chronic subdural haematoma: modern management and emerging therapies. Nat Rev Neurol. (2014) 10:570–8. 10.1038/nrneurol.2014.163 - DOI - PubMed
    1. Lee KS. Natural history of chronic subdural haematoma. Brain Inj. (2004) 18:351–8. 10.1080/02699050310001645801 - DOI - PubMed

LinkOut - more resources